David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Helix Energy Solutions
HLX
$1.47B
| $462K | ﹤0.01% |
49,588
-26,021
| -34% | -$262K |
|
|
SII
3527
Sprott
SII
$3.54B
| $459K | ﹤0.01% |
10,900
+2,800
| +35% | +$123K |
|
3528
DMC Global
BOOM
$141M
| $457K | ﹤0.01% |
62,146
-69,167
| -53% | -$653K |
|
3529
ArcelorMittal
MT
$55.5B
| $456K | ﹤0.01% |
19,722
-46,858
| -70% | -$1.16M |
|
3530
Blue Owl Capital
OWL
$18.4B
| $456K | ﹤0.01% |
+19,600
| New | +$449K |
|
|
GEAR
3531
CALL
DELISTED
Revelyst, Inc.
GEAR
| $456K | ﹤0.01% |
+23,700
| New | +$452K |
|
|
GEAR
3532
DELISTED
Revelyst, Inc.
GEAR
| $455K | ﹤0.01% |
+23,640
| New | +$451K |
|
|
NOAH
3533
Noah Holdings
NOAH
$602M
| $454K | ﹤0.01% |
+38,760
| New | +$480K |
|
3534
Biomea Fusion
BMEA
$125M
| $453K | ﹤0.01% |
+116,653
| New | +$930K |
|
3535
MaxCyte
MXCT
$139M
| $452K | ﹤0.01% |
108,601
+84,105
| +343% | +$318K |
|
3536
Transmedics
TMDX
$3.25B
| $452K | ﹤0.01% |
+7,242
| New | +$674K |
|
3537
Dimensional International Value ETF
DFIV
$22.1B
| $451K | ﹤0.01% |
+12,725
| New | +$467K |
|
3538
Gold Royalty Corp
GROY
$816M
| $451K | ﹤0.01% |
373,094
-29,992
| -7% | -$40K |
|
3539
Lifestance Health
LFST
$4.69B
| $451K | ﹤0.01% |
+61,247
| New | +$440K |
|
3540
Aquestive Therapeutics
AQST
$638M
| $450K | ﹤0.01% |
126,464
+95,418
| +307% | +$440K |
|
3541
PUT
Guardant Health
GH
$22.1B
| $449K | ﹤0.01% |
14,700
-2,200
| -13% | -$61.9K |
|
3542
PUT
Kadant
KAI
$3.58B
| $448K | ﹤0.01% |
1,300
-300
| -19% | -$109K |
|
3543
Elbit Systems
ESLT
$33.8B
| $448K | ﹤0.01% |
1,736
-391
| -18% | -$91.7K |
|
|
PSTL
3544
Postal Realty Trust
PSTL
$708M
| $448K | ﹤0.01% |
+34,319
| New | +$481K |
|
3545
KB Home
KBH
$3.5B
| $446K | ﹤0.01% |
6,787
-8,903
| -57% | -$693K |
|
3546
OceanFirst Financial
OCFC
$1.82B
| $446K | ﹤0.01% |
24,636
-87,709
| -78% | -$1.67M |
|
3547
PUT
InterDigital
IDCC
$8.92B
| $446K | ﹤0.01% |
+2,300
| New | +$402K |
|
3548
CALL
Weibo
WB
$1.75B
| $445K | ﹤0.01% |
46,600
-2,300
| -5% | -$22K |
|
3549
Apogee Therapeutics
APGE
$10.2B
| $445K | ﹤0.01% |
9,813
-39,849
| -80% | -$2.03M |
|
3550
CALL
Biogen
BIIB
$32.6B
| $443K | ﹤0.01% |
2,900
+500
| +21% | +$84.3K |
|
Similar funds
David Shaw's Q4 2024 Portfolio in Review
As of Q4 2024, David Shaw held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- David Shaw's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- David Shaw's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- David Shaw fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- David Shaw's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- David Shaw opened 591 new positions and closed 731 in Q4 2024.
- David Shaw's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.